Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1987-12-21
1989-08-22
Tanenholtz, Alvin E.
Drug, bio-affecting and body treating compositions
Lymphokine
530350, 530806, 4351723, 514 12, C07K 1500, C07K 900, C12N 1500, A61K 3912
Patent
active
048594652
ABSTRACT:
The present invention discloses a DNA transfer vector comprising two or more deoxynucleotide sequences coding for different antigenic materials linked together in phase with one another. The present invention further discloses the expression of said deoxynucleotide sequences either directly or as a fusion protein with the product of a procaryotic gene. The resulting expression product is then either a fusion protein comprising two or more antigenic materials or a fusion protein comprising a part of a procaryotic protein and two or more antigenic materials. These fusion products are capable of eliciting the formation of multivalent antibodies which are cross-reactive with any and all of the native antigenic material. A vaccine is also described utilizing these fusion products.
REFERENCES:
patent: 4366246 (1982-12-01), Riggs
patent: 4400376 (1983-08-01), Sanderson
patent: 4411994 (1983-10-01), Gilbert et al.
patent: 4415491 (1983-11-01), Vyas
Mulligan et al., Mol. Cell. Biol., vol. 14, pp. 643-654 (1979).
Natvig et al. The Journal of Immunology, vol. 112, pp. 1277-1284, (1974).
Mulligan et al., Chemical Abstract 92:125906f of ICN-UCLA Symp. Mol. Cell. Biol. (1979).
Peterson et al., PNAS U.S.A. vol. 74, pp. 1530-1534, Apr. 1977.
Goeddel et al., Nature, vol. 281, pp, 544-548, Oct. 1979.
Mercerou-Puijolon et al., Nature, vol. 275, pp. 505-510, Oct. 1978.
Helling et al., Genetic Engineering, CRC Process Inc, pp. 1,10-23 and 29 (1978).
Pasek et al., Nature, vol. 282, pp. 575-579, Dec. 6, 1979.
Budkowska et al., The Journal of Immunology, vol. 123, pp. 1415-1416, Sep. 1979.
Tanenholtz Alvin E.
The Regents of the University of California
LandOfFree
Vaccine capable of eliciting multivalent antibodies does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vaccine capable of eliciting multivalent antibodies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vaccine capable of eliciting multivalent antibodies will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2416928